An unusually frequent β-thalassemia mutation in an Iranian province

Hemoglobin

Volumn 32, Issue 4, 2008, Pages 387-392

  Eshghi, Peyman ^a   Zadeh Vakili, Azita ^b   Rashidi, Armin ^c   Miri Moghadam, Ebrahim ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Thalassemia (thal); Iran; IVS I 5 (G>C); Mutation

Indexed keywords

BETA GLOBIN;

ARTICLE; BETA THALASSEMIA; CHROMOSOME; CODON; FRAMESHIFT MUTATION; GENE MUTATION; HETEROZYGOTE; HUMAN; IRAN; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

BETA-THALASSEMIA; DNA MUTATIONAL ANALYSIS; EPIDEMIOLOGY, MOLECULAR; GENE FREQUENCY; HETEROZYGOTE; IRAN; MUTATION;

EID: 47949131536     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.1080/03630260701758932     Document Type: Article

References (27)

1. Thein SL. Genetic modifiers of β-thalassemia. Haematologica 2005; 90(5):649-660.
2. Lee GR, Forester J, Lukens J, Paraskevas F, Greer JP, Rodgers GM. Wintrobe's Clinical Hematology, 10th ed. Baltimore: Williams & Wilkins, 1999.
3. Habibzadeh F, Yadollahie M, Merat A, Haghshenas M. Thalassemia in Iran: an overview. Arch Irn Med 1998; 1(1):27-34.
4. Vetter B, Schwarz C, Kohne E, Kulozik AE. β-Thalassaemia in the immigrant and non-immigrant German populations. Br J Haematol 1997; 97(2):266-272.
5. Merat A, Haghshenas M. The spectrum of β-thalassemia mutations in Iran. Med J I R Iran 2000; 14(1):103-106.
6. van Baal S, Kaimakis P, Phommarinh M, Koumbi D, Cuppens H, Riccardino F, Macek M Jr, Scriver CR, Patrinos GP. FINDbase: a relational database recording frequencies of genetic defects leading to inherited disorders worldwide. Nucleic Acids Res 2007; 35(Database issue):D690-695.
7. Patrinos GP, Giardine B, Riemer C, Miller W, Chui DHK, Anagnou NP, Wajcman H, Hardison RC. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res 2004; 32(Database issue):D537-541 (http://globin.cse.psu.edu).
8. Hardison RC, Chui DHK, Giardine B, Riemer C, Patrinos GP, Anagnou N, Miller W, Wajcman H. HbVar: a relational database of human hemoglobin variants and thalassemia mutations at the globin gene server. Hum Mutat 2002; 19(3):225-233 (http://globin.cse.psu.edu).
9. Mahboudi F, Zeinali S, Merat A, Delmaghani S, Mostafavipour K, Moghaddam Z, Haghshenas M. The molecular basis of β-thalassemia mutations in Fars Province, Iran. Irn J Med Sci 1996; 21(3):99-104.
10. Merat A, Haghshenas M, Mostafavi Pour Z, Plonczynski MW, Harrell AN, Coleman MB, Steinberg MH. β-Thalassemia in southwestern Iran. Hemoglobin 1993; 17(5):427-437.
11. Noori-Daloii M, Moazami N, Farhangi S, Atalay A, Geren IN, Akar L, Atalay EO, Cirakoglu B, Bermek E. β-Thalassemia in Iran: a high incidence of the nonsense codon 39 mutation on the island of Queshm. Hemoglobin 1994; 18(6):449-453.
12. Yavarian M, Harteveld CL, Batelaan D, Bernini LF, Giordano PC. Molecular spectrum of β-thalassemia in the Iranian Province of Hormozgan. Hemoglobin 2001; 25(1):35-43.
13. Najmabadi H, Karimi-Nejad R, Sahebjam S, Pourfarzad F, Teimourian S, Sahebjam F, Amirizadeh N, Karimi-Nejad MH. The β-thalassemia mutation spectrum in the Iranian population. Hemoglobin 2001; 25(3):285-296.
14. Nozari G, Rahbar S, Golshaiyzan A, Rahmanzadeh S. Molecular analyses of β-thalassemia in Iran. Hemoglobin 1995; 19(6): 425-431.
15. Najmabadi H, Teimourian S, Khatibi T, Neishabury M, Pourfarzad F, Jalil-Nejad S, Azad M, Oberkanins C, Krugluger W. Amplification refractory mutation system (ARMS) and reverse hybridization in the detection of β-thalassemia mutations. Arch Irn Med 2001; 4(4):165-170.
16. Kotea N, Ramasawmy R, Lu CY, Fa NS, Gerard N, Beesoon S, Ducrocq R, Surrun SK, Nagel RL, Krishnamoorthy R. Spectrum of β thalassemia mutations and their linkage to β-globin gene haplotypes in the Indo-Mauritians. Am J Hematol 2000; 63(1):11-15.
17. Gupta A, Hattori Y, Gupta UR, Sarwai S, Nigam N, Singhal P, Agarwal S. Molecular genetic testing of β-thalassemia patients of Indian origin and a novel 8-bp deletion mutation at codons 36/37/38/39. Genet Test 2003; 7(2):163-168.
18. Khan SN, Riazuddin S. Molecular characterization of β-thalassemia in Pakistan. Hemoglobin 1998; 22(4):333-345.
19. Eshghi P, Abolghasemi H, Sanei-Moghaddam E, Anwar R, Jazebi M, Amid A, Ala FA. Factor XIII deficiency in south-east Iran. Haemophilia 2004; 10(5):470-472.
20. Daar S, Hussein HM, Merghoub T, Krishnamoorthy R. Spectrum of β-thalassemia mutations in Oman. Ann NY Acad Sci 1998; 850:404-406.
21. de Silva S, Fisher CA, Premawardhena A, Lamabadusuriya SP, Peto TE, Perera G, Old JM, Clegg JB, Olivieri NF, Weatherall DJ. Thalassaemia in Sri Lanka: implications for the future health burden of Asian populations. Sri Lanka Thalassaemia Study Group. Lancet 2000; 355(9206):786-791.
22. Kukreti R, Dash D, E VK, Chakravarty S, Das SK, De M, Talukder G. Spectrum of β-thalassemia mutations and their association with allelic sequence polymorphisms at the β-globin gene cluster in an Eastern Indian population. Am J Hematol 2002; 70(4):269-277.
23. Nigam N, Munshi N, Patel M, Soni A. Distribution of β thalassemia mutations and its correlation with α thalassemia in Gujarati families. Int J Hum Genet 2003; 3(4):221-224.
24. Garewal G, Das R. Spectrum of β-thalassemia mutations in Punjabis. Int J Hum Genet 2003; 3(4):217-219.
25. Khateeb B, Moatter T, Shaghil AM, Haroon S, Kakepoto GN. Genetic diversity of β-thalassemia mutations in Pakistani population. J Pak Med Assoc 2000; 50(9):293-296.
26. Baig SM, Azhar A, Hassan H, Baig JM, Kiyani A, Hameed U, Rabbi F, Bokhari H, Aslam M, Ud Din MA, Baig SA, Hassan K, Qureshi JA, Zaman T. Spectrum of β-thalassemia mutations in various regions of Punjab and Islamabad, Pakistan: establishment of prenatal diagnosis. Haematologica 2006; 91(3):ELT02.
27. Chakrabarti P, Gupta R, Mishra A, Rai M, Singh VP, Dash D. Spectrum of β-thalassemia mutations in North Indian states: a β-thalassemia trait with two mutations in cis. Clin Biochem 2005; 38(6):576-578.